New trends in immunosuppression and immunotherapy

International Immunopharmacology

Volumn 6, Issue 13-14, 2006, Pages 1874-1878

  Jiang, Shuiping ^a   Lombardi, Giovanna ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Immunosuppression; Immunotherapy; Tregs

Indexed keywords

ALEMTUZUMAB; AZATHIOPRINE; CALCINEURIN INHIBITOR; CARBON MONOXIDE; CORTICOSTEROID; CYCLOSPORIN; CYTOKINE RECEPTOR AGONIST; CYTOKINE RECEPTOR ANTAGONIST; DIPEPTIDYL PEPTIDASE IV; ENZYME INHIBITOR; EVEROLIMUS; FINGOLIMOD; HEME OXYGENASE 1; HIRUDIN; HYBRID PROTEIN; INTERLEUKIN 15 ANTAGONIST; INTERLEUKIN 2 RECEPTOR STIMULATING AGENT; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MICROSOMAL AMINOPEPTIDASE; MONOCLONAL ANTIBODY CD3; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 4; PROINSULIN; RAPAMYCIN; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY; TISSUE FACTOR PATHWAY INHIBITOR;

ADOPTIVE IMMUNOTHERAPY; AUTOIMMUNE DISEASE; CANCER INHIBITION; CD4+ CD25+ T LYMPHOCYTE; CLINICAL TRIAL; DRUG MEGADOSE; EDITORIAL; ENCEPHALOMYELITIS; ENTERITIS; GRAFT REJECTION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY GRAFT REJECTION; LOW DRUG DOSE; LYMPHOCYTE ACTIVATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MONOTHERAPY; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; STEM CELL TRANSPLANTATION; TUMOR GROWTH;

ADOPTIVE TRANSFER; AUTOIMMUNE DISEASES; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; PLURIPOTENT STEM CELLS; T-LYMPHOCYTES, REGULATORY;

EID: 33845188577     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2006.09.016     Document Type: Editorial

References (32)

1. Guba M., von Breitenbuch P., Steinbauer M., Koehl G., Flegel S., Hornung M., et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med 8 (2002) 128-135
2. Stallone G., Schena A., Infante B., Di Paolo S., Loverre A., Maggio G., et al. Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N Engl J Med 352 (2005) 1317-1323
3. Rowshani A.T., Bemelman F.J., van Leeuwen E.M., van Lier R.A., and ten Berge I.J. Clinical and immunologic aspects of cytomegalovirus infection in solid organ transplant recipients. Transplantation 79 (2005) 381-386
4. Tan H.P., Kaczorowski D.J., Basu A., Unruh M., McCauley J., Wu C., et al. Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy. Am J Transplant (Aug 4 2006) [Electronic publication ahead of print]
5. Watson C.J., Bradley J.A., Friend P.J., Firth J., Taylor C.J., Bradley J.R., et al. Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation-efficacy and safety at five years. Am J Transplant 5 (2005) 1347-1353
6. Knechtle S.J., Pirsch J.D., H Fechner Jr. J., Becker B.N., Friedl A., Colvin R.B., et al. Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study. Am J Transplant 3 (2003) 722-730
7. Starzl T.E., Murase N., Abu-Elmagd K., Gray E.A., Shapiro R., Eghtesad B., et al. Tolerogenic immunosuppression for organ transplantation. Lancet 361 (2003) 1502-1510
8. Wood K.J., and Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 3 (2003) 199-210
9. Jiang S., Herrera O., and Lechler R.I. New spectrum of allorecognition pathways: implications for graft rejection and transplantation tolerance. Curr Opin Immunol 16 (2004) 550-557
10. Jiang S., and Lechler R.I. Regulatory T cells in the control of transplantation tolerance and autoimmunity. Am J Transplant 3 (2003) 516-524
11. Zheng X.X., Sanchez-Fueyo A., Sho M., Domenig C., Sayegh M.H., and Strom T.B. Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance. Immunity 19 (2003) 503-514
12. Belghith M., Bluestone J.A., Barriot S., Megret J., Bach J.F., and Chatenoud L. TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat Med 9 (2003) 1202-1208
13. Bresson D., Togher L., Rodrigo E., Chen Y., Bluestone J.A., Herold K.C., et al. Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs. J Clin Invest 116 (2006) 1371-1381
14. Kohm A.P., Williams J.S., Bickford A.L., McMahon J.S., Chatenoud L., Bach J.F., et al. Treatment with nonmitogenic anti-CD3 monoclonal antibody induces CD4+ T cell unresponsiveness and functional reversal of established experimental autoimmune encephalomyelitis. J Immunol 174 (2005) 4525-4534
15. Ochi H., Abraham M., Ishikawa H., Frenkel D., Yang K., Basso A.S., et al. Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+ CD25- LAP+ T cells. Nat Med 12 (2006) 627-635
16. Gregori S., Mangia P., Bacchetta R., Tresoldi E., Kolbinger F., Traversari C., et al. An anti-CD45RO/RB monoclonal antibody modulates T cell responses via induction of apoptosis and generation of regulatory T cells. J Exp Med 201 (2005) 1293-1305
17. Waldmann H., Adams E., Fairchild P., and Cobbold S. Infectious tolerance and the long-term acceptance of transplanted tissue. Immunol Rev 212 (2006) 301-313
18. Chang C.C., Ciubotariu R., Manavalan J.S., Yuan J., Colovai A.I., Piazza F., et al. Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol 3 (2002) 237-243
19. Jiang S., Camara N., Lomabardi G., and Lechler R.I. Induction of allopeptide-specific human CD4+CD25+ regulatory T cells ex vivo. Blood 102 (2003) 2180-2186
20. Golshayan D, Jiang S, Tsang J, Garin M, Mottet C, Lechler RI. In vitro-expanded allopeptide-specific murine CD4+CD25+ regulatory T cells induced donor-specific experimental transplantation tolerance. Blood. in press.
21. Jiang S, Tsang J, Stevenson S, Game D, Lombardi G, Lechler RI. Generation and Expansion of Human CD4+CD25+ Regulatory T Cells with Indirect Allospecificity: Potential Reagents to Promote Donor-specific Transplantation Tolerance. Transplantation. in press.
22. Tang Q., and Bluestone J.A. Regulatory T-cell physiology and application to treat autoimmunity. Immunol Rev 212 (2006) 217-237
23. Hackstein H., and Thomson A.W. Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat Rev Immunol 4 (2004) 24-34
24. Pribylova-Hribova P., Kotsch K., Lodererova A., Viklicky O., Vitko S., Volk H.D., et al. TGF-beta1 mRNA upregulation influences chronic renal allograft dysfunction. Kidney Int 69 (2006) 1872-1879
25. Augustine J.J., Siu D.S., Clemente M.J., Schulak J.A., Heeger P.S., and Hricik D.E. Pre-transplant IFN-gamma ELISPOTs are associated with post-transplant renal function in African American renal transplant recipients. Am J Transplant 5 (2005) 1971-1975
26. Ochando JC, Homma C, Yang Y, Hilalgo A, Garin A, Tacke F., et al. Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat Immun. 7: 652-662.
27. Roberts T.J., Price J., Williams S.C., and Modo M. Preservation of striatal tissue and behavioral function after neural stem cell transplantation in a rat model of Huntington's disease. Neuroscience 139 (2006) 1187-1199
28. McWhir J., Wojtacha D., and Thomson A. Routine culture and differentiation of human embryonic stem cells. Methods Mol Biol 331 (2006) 77-90
29. Zhou W., Patel H., Li K., Peng Q., Villiers M.B., and Sacks S.H. Macrophages from C3-deficient mice have impaired potency to stimulate alloreactive T cells. Blood 107 (2006) 2461-2469
30. Chen D., Giannopoulos K., Shiels P.G., Webster Z., McVey J.H., Kemball-Cook G., et al. Inhibition of intravascular thrombosis in murine endotoxemia by targeted expression of hirudin and tissue factor pathway inhibitor analogs to activated endothelium. Blood 104 (2004) 1344-1349
31. Yamashita K., Ollinger R., McDaid J., Sakahama H., Wang H., Tyagi S., et al. Heme oxygenase-1 is essential for and promotes tolerance to transplanted organs. FASEB J 20 (2006) 776-778
32. Steinbrecher A., Reinhold D., Quigley L., Gado A., Tresser N., Izikson L., et al. Targeting dipeptidyl peptidase IV (CD26) suppresses autoimmune encephalomyelitis and up-regulates TGF-beta 1 secretion in vivo. J Immunol 166 (2001) 2041-2048